These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10932343)

  • 41. [Changes in lung capacity under the influence of bronchodilators in patients with chronic obstructive lung diseases].
    Grebska E; Radwan L
    Pneumonol Pol; 1979 Nov; 47(11):775-80. PubMed ID: 503878
    [No Abstract]   [Full Text] [Related]  

  • 42. [The hypersensitive bronchial system. Significance for prognosis inhibition of progression of chronic obstructive respiratory tract diseases].
    Nowak D; Magnussen H
    Internist (Berl); 1993 Apr; 34(4):294-9. PubMed ID: 8486472
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of bronchodilator response in patients with airway obstruction.
    Quadrelli SA; Roncoroni AJ; Montiel GC
    Respir Med; 1999 Sep; 93(9):630-6. PubMed ID: 10542976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 45. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
    Pauwels RA; Buist AS; Calverley PM; Jenkins CR; Hurd SS;
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1256-76. PubMed ID: 11316667
    [No Abstract]   [Full Text] [Related]  

  • 46. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
    Celik G; Kayacan O; Beder S; Durmaz G
    Respiration; 1999; 66(5):434-9. PubMed ID: 10516540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease.
    Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E
    Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive care of COPD.
    Petty TL; Cherniack RM
    Clin Notes Respir Dis; 1981; 20(3):3-12. PubMed ID: 7318265
    [No Abstract]   [Full Text] [Related]  

  • 49. Predicting response to bronchodilator therapy in chronic obstructive pulmonary disease.
    Pratter MR; Irwin RS
    Arch Intern Med; 1988 Sep; 148(9):1909-10. PubMed ID: 3415402
    [No Abstract]   [Full Text] [Related]  

  • 50. [COPD--a diagnostic and therapeutic challenge. Congress report on the workshop of Boehringer Ingelheim Pharma KG on March 3 20000 in Hamburg in the framework of the 20th congress of the German Society of Pneumology].
    Gillissen A
    Pneumologie; 2000 Jul; 54(7):306-8. PubMed ID: 11008468
    [No Abstract]   [Full Text] [Related]  

  • 51. [Oxygen saturation during sleep in chronic obstructive lung diseases before and after bronchodilator therapy. A controlled, prospective study in 36 patients].
    Schmid T; Dreher D; Karrer W
    Schweiz Med Wochenschr; 1988 Nov; 118(45):1645-50. PubMed ID: 3187481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High resolution computed tomography (HRCT) assessment of beta 2-agonist induced bronchodilation in chronic obstructive pulmonary disease patients.
    De Luca N; Capuzi P; D'Angeli AL; D'Antoni L; Pavone P; De Santis M; Di Girolamo M; Catalano C; Passariello R
    Eur Rev Med Pharmacol Sci; 1999; 3(2):83-7. PubMed ID: 10827809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospects for improved therapy in chronic obstructive pulmonary disease by the use of levalbuterol.
    Costello J
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S61-8. PubMed ID: 10452790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic obstructive lung disease.
    Musk AW
    Aust Fam Physician; 1987 May; 16(5):589, 593, 595. PubMed ID: 3606496
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapeutic options in the management of stable chronic obstructive lung disease (COPD)].
    Schäfer H; Ewig S; Gillissen A
    Dtsch Med Wochenschr; 2000 Feb; 125(8):230-5. PubMed ID: 10723464
    [No Abstract]   [Full Text] [Related]  

  • 56. Physiologic features of upper airway obstruction.
    Sackner MA
    Chest; 1972 Oct; 62(4):414-7. PubMed ID: 5077997
    [No Abstract]   [Full Text] [Related]  

  • 57. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness.
    Chen C; Jian W; Gao Y; Xie Y; Song Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2519-2526. PubMed ID: 27785008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.
    Hansen EF; Phanareth K; Laursen LC; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1267-71. PubMed ID: 10194175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spirometric indices after bronchodilator test in obstructive lung disease.
    Mehrparvar AH; Mirmohammadi SJ; Sohrabi MM
    Acta Med Iran; 2010; 48(4):226-30. PubMed ID: 21279934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of a new anticholinergic bronchodilator aerosol, 8-isopropylscopolamine bromide, on chronic obstructive pulmonary disease].
    Huang ZB
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Feb; 7(1):24-7. PubMed ID: 6147238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.